scholarly article | Q13442814 |
P2093 | author name string | Gary D Anderson | |
Ben S Zweifel | |||
Jaime L Masferrer | |||
Dawn Dufield | |||
Robert A Pufahl | |||
Matthew Graneto | |||
Luz Cortes-Burgos | |||
Medora Hardy | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
P304 | page(s) | 294-301 | |
P577 | publication date | 2010-04-08 | |
P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
P1476 | title | Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain | |
P478 | volume | 334 |
Q34208803 | 5-Lipoxygenase inhibitors attenuate TNF-α-induced inflammation in human synovial fibroblasts |
Q41909598 | A fluorescence-based assay for measuring the redox potential of 5-lipoxygenase inhibitors |
Q89411784 | Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid |
Q43928450 | Bioguidage search of active compounds from Waltheria indica L. (Malvaceae) used for asthma and inflammation treatment in Burkina Faso |
Q50541287 | Computer modeling in predicting the bioactivity of human 5-lipoxygenase inhibitors. |
Q51189605 | Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis. |
Q28534270 | Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapy |
Q33955652 | Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase |
Q37385704 | Esculetin reduces leukotriene B4 level in plasma of rats with adjuvant-induced arthritis |
Q33880198 | Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis |
Q28296738 | Recent advances in the search for novel 5-lipoxygenase inhibitors |
Q34475033 | Regulation of leukotriene and 5oxoETE synthesis and the effect of 5-lipoxygenase inhibitors: a mathematical modeling approach |
Q36176531 | The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice |
Search more.